Skip to content
DraconiticResearch
Search Sources API
181,713 studies31 sourcesUpdated 1 min ago
PreprintLicence not statedChemRxiv

Design and Benchmarking of CK2α′-Preferring Inhibitors for Huntington’s Disease: The Limits of Structure-Based Isoform Selectivity

  • Tarun Tarun
Open at sourceDOICite

Related

  1. Checkmate for CHK2: Discovery of First-in-Class Covalent CHK2 Inhibitors with High Potency and Selectivity
    Xiaojun Julia Liang, Janosch Rheinganz, Fabian B. Kraft +12
    ChemRxivPreprintCC BYFull textOrganic chemistryChemRxiv
  2. Benchmarking Affinity-Based Docking for Irreversible Acetylcholinesterase Inhibitors: A Physics-Informed Reactivity Framework for Stereoselective Potency Prioritization
    Jeongyun Kim, Jin Yoo, Doo-Hee Lee +1
    ACS omegaPeer-reviewedCC BY-NC-NDFull textGeneral chemistryEurope PMCCrossref
  3. Selectivity of acid–base extraction routes and their effects on the structure, physicochemical properties, and adsorption performance of shrimp-shell-derived chitosan
    Abdul Moiz, Rabia Aziz, Abdul Hannan +7
    RSC AdvancesPeer-reviewedCC BY-NC 3.0Full textMaterials & polymersPMC
  4. Structure-based virtual screening identifies naturally derived histidine kinase VbrK inhibitors as potential countermeasures against β-lactam antimicrobial resistance
    Chao Yan, Xiaoyi Li, Jiayin Wang +3
    RSC Medicinal ChemistryPeer-reviewedPublisher termsFull textGeneral chemistryPMC
  5. Two-Dimensional C60 Fullerene Networks (Graphullerene): Structure–Property Relations, Quantitative Benchmarking and Future Directions
    Giorgos S. Avntoulla, Georgios I. Giannopoulos
    NanomaterialsPeer-reviewedCC BY 4.0Organic chemistryCrossref

Cite

BibTeXRIS
BibTeX
@misc{tarun2026design,
  title = {{Design and Benchmarking of CK2α′-Preferring Inhibitors for Huntington’s Disease: The Limits of Structure-Based Isoform Selectivity}},
  author = {Tarun Tarun},
  howpublished = {ChemRxiv},
  year = {2026},
  month = nov,
  doi = {10.26434/chemrxiv.15011551/v1},
  url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011551/v1},
}
RIS
TY  - UNPB
TI  - Design and Benchmarking of CK2α′-Preferring Inhibitors for Huntington’s Disease: The Limits of Structure-Based Isoform Selectivity
AU  - Tarun Tarun
PY  - 2026
DA  - 2026/11/02
PB  - ChemRxiv
DO  - 10.26434/chemrxiv.15011551/v1
UR  - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15011551/v1
ER  -